Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Applied Toxicology : JAT
|
July 23, 2015
Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media
Yuying Xue, Ting Zhang, Bangyong Zhang, et al.
Ecotoxicology and Environmental Safety
|
November 1, 2020
Mitophagy-lysosomal pathway is involved in silver nanoparticle-induced apoptosis in A549 cells
Jiangyan Li, Xiaoru Chang, Mengting Shang, et al.
Environmental Pollution (Barking, Essex : 1987)
|
November 6, 2019
Silver nanoparticles modulate mitochondrial dynamics and biogenesis in HepG2 cells
Jiangyan Li, Bangyong Zhang, Xiaoru Chang, et al.
Nature Communications
|
February 3, 2024
The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial
Qiao Li, Jiaxuan Liu, Qingyuan Zhang, et al.
Journal for Immunotherapy of Cancer
|
June 1, 2023
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors
Yuxiang Ma, Jinhui Xue, Yuanyuan Zhao, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Applied Toxicology : JAT
|
July 23, 2015
Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media
Yuying Xue, Ting Zhang, Bangyong Zhang, et al.
Ecotoxicology and Environmental Safety
|
November 1, 2020
Mitophagy-lysosomal pathway is involved in silver nanoparticle-induced apoptosis in A549 cells
Jiangyan Li, Xiaoru Chang, Mengting Shang, et al.
Environmental Pollution (Barking, Essex : 1987)
|
November 6, 2019
Silver nanoparticles modulate mitochondrial dynamics and biogenesis in HepG2 cells
Jiangyan Li, Bangyong Zhang, Xiaoru Chang, et al.
Nature Communications
|
February 3, 2024
The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial
Qiao Li, Jiaxuan Liu, Qingyuan Zhang, et al.
Journal for Immunotherapy of Cancer
|
June 1, 2023
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors
Yuxiang Ma, Jinhui Xue, Yuanyuan Zhao, et al.
Page
of 1